Skip to main content
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2005 Jun;81(3):248–253. doi: 10.1136/sti.2004.011544

Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland

S Plitt 1, S Sherman 1, S Strathdee 1, T Taha 1
PMCID: PMC1744972  PMID: 15923296

Abstract

Objectives: To examine the sex specific seroprevalence and correlates of herpes simplex virus 2 (HSV-2) and syphilis among a cohort of young drug users.

Methods: Drug users aged 15–30 years old who used heroin, cocaine, or crack were recruited between October 1999 and August 2002. Baseline interviews gathered information on sociodemographics, drug use and sexual behaviours. Serum was tested at baseline for HSV-2 and syphilis seroreactivity. For each sexually transmitted infection (STI), infected and non-infected participants were stratified by sex and compared using χ2, Mann-Whitney tests, and logistic regression.

Results: Of the 543 participants recruited, 42.4% were female and 39.3% were African-American. The seroprevalence of STIs among females and males, respectively, were HSV-2: 58.7% and 22.0%; syphilis: 4.3% and 0.3%. In multivariate models, older age, African-American race, having over 30 lifetime sex partners, current HIV infection and previous incarceration were independently associated with HSV-2 infection among males. For females, older age, African-American race, sex trade, and daily heroin use were independently associated with HSV-2. For females, only a self reported previous syphilis diagnosis was associated with current syphilis seroreactivity in multivariate analyses.

Conclusions: Examination of this cohort revealed a particularly high seroprevalence of HSV-2 and syphilis, especially among female drug users. Few infected participants had been previously diagnosed with these infections.

Full Text

The Full Text of this article is available as a PDF (81.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruneau J., Lamothe F., Soto J., Lachance N., Vincelette J., Vassal A., Franco E. L. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ. 2001 Mar 20;164(6):767–773. [PMC free article] [PubMed] [Google Scholar]
  2. Cherpes Thomas L., Meyn Leslie A., Krohn Marijane A., Hillier Sharon L. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis. 2003 May;30(5):405–410. doi: 10.1097/00007435-200305000-00006. [DOI] [PubMed] [Google Scholar]
  3. Cohen E., Navaline H., Metzger D. High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women. J Psychoactive Drugs. 1994 Jul-Sep;26(3):233–241. doi: 10.1080/02791072.1994.10472436. [DOI] [PubMed] [Google Scholar]
  4. Dickerson M. C., Johnston J., Delea T. E., White A., Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis. 1996 Sep-Oct;23(5):429–440. doi: 10.1097/00007435-199609000-00015. [DOI] [PubMed] [Google Scholar]
  5. Evans Jennifer L., Hahn Judith A., Page-Shafer Kimberly, Lum Paula J., Stein Ellen S., Davidson Peter J., Moss Andrew R. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar;80(1):137–146. doi: 10.1093/jurban/jtg137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Finelli Lyn, Farley Thomas P., Gibson James J., Langley Carol, Hwang Lu-Yu, Levine William C. Prevalence monitoring in syphilis surveillance: results from a multicenter research program. Sex Transm Dis. 2002 Dec;29(12):769–774. doi: 10.1097/00007435-200212000-00006. [DOI] [PubMed] [Google Scholar]
  7. Fleming D. T., McQuillan G. M., Johnson R. E., Nahmias A. J., Aral S. O., Lee F. K., St Louis M. E. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997 Oct 16;337(16):1105–1111. doi: 10.1056/NEJM199710163371601. [DOI] [PubMed] [Google Scholar]
  8. Fleming D. T., Wasserheit J. N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb;75(1):3–17. doi: 10.1136/sti.75.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fuller Crystal M., Vlahov David, Ompad Danielle C., Shah Nina, Arria Amelia, Strathdee Steffanie A. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002 Apr 1;66(2):189–198. doi: 10.1016/s0376-8716(01)00200-9. [DOI] [PubMed] [Google Scholar]
  10. Gottlieb Sami L., Douglas John M., Jr, Schmid D. Scott, Bolan Gail, Iatesta Michael, Malotte C. Kevin, Zenilman Jonathan, Foster Mark, Barón Anna E., Steiner John F. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis. 2002 Oct 23;186(10):1381–1389. doi: 10.1086/344317. [DOI] [PubMed] [Google Scholar]
  11. Hahn R. A., Magder L. S., Aral S. O., Johnson R. E., Larsen S. A. Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic study. Am J Public Health. 1989 Apr;79(4):467–470. doi: 10.2105/ajph.79.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henderson D. J., Boyd C., Mieczkowski T. Gender, relationships, and crack cocaine: a content analysis. Res Nurs Health. 1994 Aug;17(4):265–272. doi: 10.1002/nur.4770170405. [DOI] [PubMed] [Google Scholar]
  13. Hwang L. Y., Ross M. W., Zack C., Bull L., Rickman K., Holleman M. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis. 2000 Oct 25;31(4):920–926. doi: 10.1086/318131. [DOI] [PubMed] [Google Scholar]
  14. Kim M. Y., Marmor M., Dubin N., Wolfe H. HIV risk-related sexual behaviors among heterosexuals in New York City: associations with race, sex, and intravenous drug use. AIDS. 1993 Mar;7(3):409–414. doi: 10.1097/00002030-199303000-00016. [DOI] [PubMed] [Google Scholar]
  15. Larsen S. A., Steiner B. M., Rudolph A. H. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995 Jan;8(1):1–21. doi: 10.1128/cmr.8.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. López-Zetina J., Ford W., Weber M., Barna S., Woerhle T., Kerndt P., Monterroso E. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6. Sex Transm Infect. 2000 Dec;76(6):462–469. doi: 10.1136/sti.76.6.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McCoy C. B., Metsch L. R., Chitwood D. D., Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001 May-Jun;36(6-7):789–806. doi: 10.1081/ja-100104091. [DOI] [PubMed] [Google Scholar]
  18. Powis B., Griffiths P., Gossop M., Strang J. The differences between male and female drug users: community samples of heroin and cocaine users compared. Subst Use Misuse. 1996 Apr;31(5):529–543. doi: 10.3109/10826089609045825. [DOI] [PubMed] [Google Scholar]
  19. Ross M. W., Hwang L. Y., Leonard L., Teng M., Duncan L. Sexual behaviour, STDs and drug use in a crack house population. Int J STD AIDS. 1999 Apr;10(4):224–230. doi: 10.1258/0956462991913989. [DOI] [PubMed] [Google Scholar]
  20. Røttingen J. A., Cameron D. W., Garnett G. P. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001 Oct;28(10):579–597. doi: 10.1097/00007435-200110000-00005. [DOI] [PubMed] [Google Scholar]
  21. Schacker T., Ryncarz A. J., Goddard J., Diem K., Shaughnessy M., Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA. 1998 Jul 1;280(1):61–66. doi: 10.1001/jama.280.1.61. [DOI] [PubMed] [Google Scholar]
  22. Spinola S. M., Orazi A., Arno J. N., Fortney K., Kotylo P., Chen C. Y., Campagnari A. A., Hood A. F. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis. 1996 Feb;173(2):394–402. doi: 10.1093/infdis/173.2.394. [DOI] [PubMed] [Google Scholar]
  23. Stanberry L., Cunningham A., Mertz G., Mindel A., Peters B., Reitano M., Sacks S., Wald A., Wassilew S., Woolley P. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res. 1999 May;42(1):1–14. doi: 10.1016/s0166-3542(99)00004-2. [DOI] [PubMed] [Google Scholar]
  24. Williams M. L., Elwood W. N., Weatherby N. L., Bowen A. M., Zhao Z., Saunders L. A., Montoya I. D. An assessment of the risks of syphilis and HIV infection among a sample of not-in-treatment drug users in Houston, Texas. AIDS Care. 1996 Dec;8(6):671–682. doi: 10.1080/09540129650125380. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES